GHTM

Global Health and Tropical Medicine

  • GHTM
    • About GHTM
    • Governance
    • Impact
    • Members
    • Scientific Advisory Board
    • Reports
      • GHTM
  • Research
    • Cross-cutting issues
      • Antimicrobial Resistance and Drug Discovery
      • Host–Pathogen Interactions
      • Genomic Surveillance and Population Mobility
      • Implementation and Translational Research
      • Information for Health Development
      • Fair Research Partnerships
    • Research Groups
      • PPS – Population health, policies and services
      • PRIME – Pathogen resistance, infection and molecular epidemiology
      • VBD – Vector borne diseases
      • CTM – Clinical tropical medicine
    • Research in numbers
    • Projects
      • Ongoing Projects
      • Completed Projects
  • Outreach
    • Events
    • News
    • Policy Support & Community Outreach
  • Publications
    • 2024
    • 2023
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
  • Capacity Building
    • Education
      • Master Theses
      • PhD Theses
    • International
  • Infrastructures
    • BIOHUB & Available Software
    • BIOTROP Biobank
    • VIASEF & Insectaries
  • Networks & Partnerships
Home / miL3DSkin

miL3DSkin

New approaches to neglected cutaneous leishmaniasis: three-dimensional (3D) skin models and miRNA

 

Cutaneous leishmaniasis (CL) is a neglected tropical disease caused by protozoan parasites of the genus Leishmania. Transmitted through the bite of infected female phlebotomine sand flies, this disease affects both humans and animals.

Dogs play a central role in the epidemiology of leishmaniasis, acting as the main reservoir host. In canine cutaneous leishmaniosis (canCL), infection leads to painful skin lesions, ulceration, and bleeding, significantly compromising animal welfare and quality of life.

At the core of disease development lies the complex interaction between the parasite and the host immune system. Understanding these interactions is critical for identifying mechanisms of infection establishment, immune evasion, and disease progression.

In recent years, increased mobility of companion animals, coupled with climate and environmental changes, has contributed to the spread of both vectors and parasites, including non-endemic Leishmania species. This evolving scenario highlights the urgent need for integrated research strategies under the One Health framework, recognizing the interconnected health of humans, animals, and ecosystems.

 

Objective

miL3DSkin aims to study the early stages of Leishmania infection and the host immune response. A particular  focus will be placed on:

  • The role of extracellular vesicles (EVs) as mediators of parasite–host communication
  • The function of microRNAs (miRNAs) in regulating host immune responses during infection

By integrating these elements, miL3Dskin team seeks to uncover molecular mechanisms that determine infection outcomes and disease progression in dogs.

Innovation

miL3DSkin introduces a pioneering and integrative approach to the study of canine cutaneous leishmaniosis (canCL), by combining:

  • 3D tissue-engineered skin models, which closely mimic the structure and function of living tissue
  • Extracellular vesicle (EVs) biology, an emerging field revealing new modes of intercellular communication
  • miRNA profiling, enabling detailed analysis of gene regulation during infection

The project will follow a multidisciplinary strategy integrating cell biology, molecular biology, and immunology. This approach not only improves biological relevance but also aligns with ethical efforts to reduce animal experimentation while enhancing data quality.

Ultimately, miL3DSkin may contribute to the development of innovative, affordable, and effective strategies to prevent and control leishmaniasis, promoting healthier communities and ecosystems.

By removing blood from the equation, BLOODless significantly reduces the risk of accidentally introducing pathogens into mosquito colonies—an essential advantage for public health programs and research settings. Its long shelf life and ease of storage make it especially valuable in remote or resource-limited environments where malaria is most prevalent.

Who Can Benefit

  • Insectaries and vector biology research labs

  • Organizations developing malaria vaccines or genetically modified mosquitoes

  • Vector control programs in malaria-endemic regions

  • Public health agencies and nonprofits focused on disease elimination

Contact & Collaboration

We’re actively seeking licensing partners, co-development collaborators, and organizations interested in implementing BLOODLESS in large-scale mosquito rearing or disease control programs.

Whether you’re in research, public health, biotech, or working in malaria-endemic regions, we’d love to hear from you.

📩 Get in touch:
Email us at bloodless@ihmt.unl.pt or find us at NOVA INNOVATION and IHMT-NOVA.

Intellectual Property
WO2019198013; EP3802584; US2021030025
Publications
Marques, J., Seabra, S.G., Almeida, I. et al. Long-term blood-free rearing of Anopheles mosquitoes with no effect on fitness, Plasmodium infectivity nor microbiota composition. Sci Rep 14, 19473 (2024). DOI: 10.1038/s41598-024-70090-6
Marques, J, Cardoso JCR, Felix RC, Santana RAG, Guerra MGB, Power D, Silveira H. 2018. Fresh-blood-free diet for rearing malaria mosquito vectors. Sci Rep. 8:17807. DOI: 10.1038/s41598-018-35886-3
Marques, J, Cardoso JCR, Felix RC, Power D, Silveira H. 2020. A Blood-Free Diet to Rear Anopheline Mosquitoes. J. Vis. Exp. (155), e60144, DOI: 10.3791/60144
 

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • Share on LinkedIn (Opens in new window) LinkedIn
  • Share on Pinterest (Opens in new window) Pinterest
  • Share on WhatsApp (Opens in new window) WhatsApp
  • Print (Opens in new window) Print

About GHTM

GHTM is a R&D Unit that brings together researchers with a track record in Tropical Medicine and International & Global Health. It aims at strengthening Portugal's role as a leading partner in the development and implementation of a global health research agenda. Our evidence-based interventions contribute to the promotion of equity in health and to improve the health of populations.

Contacts

Rua da Junqueira, 100
1349-008 Lisboa
Portugal

+351 213 652 600

  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

Funding

UID/04413/2025 - DOI: 10.54499/UID/04413/2025

UID/PRR/04413/2025 - DOI: 10.54499/UID/PRR/04413/2025

UID/PRR2/04413/2025 - DOI: 10.54499/UID/PRR2/04413/2025

  • Events
  • Research Groups
  • Cross-cutting issues
© Copyright 2026 IHMT-UNL All Rights Reserved.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    UIDB/04413/2020
    UIDP/04413/2020

Loading Comments...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.